IL163521A0 - Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secretesd from the hypot - Google Patents

Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secretesd from the hypot

Info

Publication number
IL163521A0
IL163521A0 IL16352197A IL16352197A IL163521A0 IL 163521 A0 IL163521 A0 IL 163521A0 IL 16352197 A IL16352197 A IL 16352197A IL 16352197 A IL16352197 A IL 16352197A IL 163521 A0 IL163521 A0 IL 163521A0
Authority
IL
Israel
Prior art keywords
salts
peptide
formula
secretesd
hypot
Prior art date
Application number
IL16352197A
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of IL163521A0 publication Critical patent/IL163521A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IL16352197A 1996-06-21 1997-06-19 Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secretesd from the hypot IL163521A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16179196 1996-06-21
PCT/JP1997/002097 WO1997048726A1 (en) 1996-06-21 1997-06-19 Method for producing peptides

Publications (1)

Publication Number Publication Date
IL163521A0 true IL163521A0 (en) 2005-12-18

Family

ID=15741986

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16352197A IL163521A0 (en) 1996-06-21 1997-06-19 Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secretesd from the hypot
IL12731297A IL127312A0 (en) 1996-06-21 1997-06-19 Method for producing peptides
IL163521A IL163521A (en) 1996-06-21 2004-08-12 Peptide with formula 5 - OXO - Pro - R1 - Trp - Ser - R2 - R3 - OR9

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL12731297A IL127312A0 (en) 1996-06-21 1997-06-19 Method for producing peptides
IL163521A IL163521A (en) 1996-06-21 2004-08-12 Peptide with formula 5 - OXO - Pro - R1 - Trp - Ser - R2 - R3 - OR9

Country Status (13)

Country Link
US (1) US6211333B1 (de)
EP (1) EP0910575B1 (de)
KR (1) KR100459978B1 (de)
CN (1) CN1129607C (de)
AT (1) ATE224912T1 (de)
AU (1) AU3189997A (de)
CA (1) CA2257381C (de)
DE (1) DE69715860T2 (de)
DK (1) DK0910575T3 (de)
ES (1) ES2184096T3 (de)
IL (3) IL163521A0 (de)
PT (1) PT910575E (de)
WO (1) WO1997048726A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6492372B1 (en) 1999-01-22 2002-12-10 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
ATE323102T1 (de) * 1999-01-26 2006-04-15 Elan Pharm Inc Pyroglutaminsäurederivate und damit verwandte verbindungen, die die durch vla-4 vermittelte leukozytenadhäsion verringern
WO2001002428A1 (en) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Process for the preparation of lh-rh derivatives
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
CN100399930C (zh) * 2002-07-29 2008-07-09 安敏诺技术公司 肽/氨基酸的生产方法、通过所述方法生产的肽/氨基酸及其应用
ES2336826T3 (es) * 2005-05-03 2010-04-16 Novetide, Ltd. Procedimientos para la produccion de un peptido que presenta una amida c-terminal.
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
BRPI0616643A2 (pt) 2005-09-29 2011-06-28 Elan Pharm Inc compostos de carbamato que inibem a adesão leucocitária mediada por vla-4
KR20080100271A (ko) 2006-02-27 2008-11-14 엘란 파마슈티칼스, 인크. Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물
EP2424841A1 (de) 2009-04-27 2012-03-07 Elan Pharmaceuticals Inc. Pyridinonantagonisten von alpha-4-integrinen
JP6564539B1 (ja) 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947569A (en) * 1972-04-12 1976-03-30 American Home Products Corporation Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor
US3855198A (en) 1972-09-29 1974-12-17 American Home Prod Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
JPS49100081A (de) 1973-01-30 1974-09-20
CA1023350A (en) 1974-01-21 1977-12-27 Manfred K. Gotz Derivatives of the lh- and fsh-releasing hormone
CH611878A5 (de) 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
EP0033976B1 (de) 1980-02-12 1984-05-30 Takeda Chemical Industries, Ltd. Verfahren zum Schutz der Guanidingruppe und deren Wiederherstellung
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
DE68928278T2 (de) * 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog

Also Published As

Publication number Publication date
CA2257381C (en) 2007-08-21
IL163521A (en) 2007-07-04
ES2184096T3 (es) 2003-04-01
ATE224912T1 (de) 2002-10-15
US6211333B1 (en) 2001-04-03
IL127312A0 (en) 1999-09-22
CN1129607C (zh) 2003-12-03
DE69715860T2 (de) 2003-08-07
CA2257381A1 (en) 1997-12-24
AU3189997A (en) 1998-01-07
DE69715860D1 (de) 2002-10-31
EP0910575B1 (de) 2002-09-25
DK0910575T3 (da) 2003-02-03
KR100459978B1 (ko) 2005-01-15
WO1997048726A1 (en) 1997-12-24
PT910575E (pt) 2003-02-28
EP0910575A1 (de) 1999-04-28
KR20000016798A (ko) 2000-03-25
CN1222916A (zh) 1999-07-14

Similar Documents

Publication Publication Date Title
IL127312A0 (en) Method for producing peptides
GB1498048A (en) Decapeptide amides
ATE176904T1 (de) Verfahren zur herstellung von phenylalanin- derivaten oder homologen, die eine guanidin- oder modifizierte guanidin-gruppe enthalten, verwendbar für die herstellung von gnrh antagonistisch wirksamen peptiden
ES486572A1 (es) Procedimiento para la fabricacion de acidos treo-3-amino-2- hidroxibutanoil amonoaceticos.
ES8200645A1 (es) Un procedimiento para la preparacion de un muramildipeptido.
US4124577A (en) Nonapeptides and methods for their production
IL124623A0 (en) Agents for promoting bone formation
KR900009692A (ko) 레트로바이러스 프로테아제 억제제
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
GB1532211A (en) Lh-rh peptide analogues
CA1142514A (en) Pharmacologically active peptides
WO1991019737A1 (en) Method of making peptides
US3757003A (en) Process for preparing l pyroglutamyl l histidyl l prolinamide
US4322342A (en) Analgesic compounds
EP0297456A3 (de) Immunsuppressive Peptide
ES2160595T3 (es) Tratamiento de hepatomas con analogos de somatostatina.
EP0030848A2 (de) Peptide mit pharmakologischer Wirkung, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4087419A (en) Heptapeptides and methods for their production
CA1186683A (en) Nonapeptide, a process for its preparation, an agent containing it and its use
ES8207510A1 (es) Un metodo de preparacion de un peptido inhibidor de la liberacion de gonadotropinas por la glandula pituitaria en mamiferos.
HU181402B (en) Process for preparing new peptides with psychopharmacological activity
US4035348A (en) Tetrapeptides and methods for their production
US4022760A (en) Tripeptides and methods for their production
Ueki et al. Phosphinyl-and phosphinothioylamino acids and peptides. VIII. New practical removal conditions for the S-Mpt group and their application for the synthesis of bis (N, N-diallyl-(D-Ala2, L-Leu5)-enkephalyl) cystine.
US4031069A (en) Tetrapeptides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed